Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (211-220 of 287) with videos related to

Pageof 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical statusP Lissoni, S Barni, M Mandalà, et al.
Tumori|July 1, 1995
Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1P Lissoni, S Barni, A Ardizzoia, et al.
Anticancer Research|June 25, 2003
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinationsG Cerea, M Vaghi, A Ardizzoia, et al.
The International Journal of Biological Markers|April 14, 2000
Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancerP Lissoni, F Brivio, R Ferrante, et al.
Journal of Endocrinological Investigation|February 1, 1988
The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in manD Esposti, P Lissoni, R Mauri, et al.
Oncology|May 1, 1995
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folatesS Barni, P Lissoni, M Cazzaniga, et al.
Tumori|June 30, 1991
Neuroendocrine effects of subcutaneous interleukin-2 injection in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
Oncology|January 1, 1990
Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancerP Lissoni, S Crispino, S Barni, et al.
Recenti Progressi in Medicina|June 1, 1995
Prevention of interleukin-2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatoninE R Bregani, P Lissoni, F Rossini, et al.
Journal of Endocrinological Investigation|August 1, 1985
Effects of melatonin on PRL secretion during different photoperiods of the day in prepubertal and pubertal healthy subjectsR Mauri, P Lissoni, M Resentini, et al.
Pageof 29

Showing results (211-220 of 287) with videos related to

Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical statusP Lissoni, S Barni, M Mandalà, et al.
Tumori|July 1, 1995
Clinical efficacy of cancer subcutaneous immunotherapy with interleukin-2 in relation to the pretreatment levels of tumor growth factor insulin-like growth factor-1P Lissoni, S Barni, A Ardizzoia, et al.
Anticancer Research|June 25, 2003
Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinationsG Cerea, M Vaghi, A Ardizzoia, et al.
The International Journal of Biological Markers|April 14, 2000
Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancerP Lissoni, F Brivio, R Ferrante, et al.
Journal of Endocrinological Investigation|February 1, 1988
The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in manD Esposti, P Lissoni, R Mauri, et al.
Oncology|May 1, 1995
A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folatesS Barni, P Lissoni, M Cazzaniga, et al.
Tumori|June 30, 1991
Neuroendocrine effects of subcutaneous interleukin-2 injection in cancer patientsP Lissoni, S Barni, F Rovelli, et al.
Oncology|January 1, 1990
Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancerP Lissoni, S Crispino, S Barni, et al.
Recenti Progressi in Medicina|June 1, 1995
Prevention of interleukin-2-induced thrombocytopenia during the immunotherapy of cancer by a concomitant administration of the pineal hormone melatoninE R Bregani, P Lissoni, F Rossini, et al.
Journal of Endocrinological Investigation|August 1, 1985
Effects of melatonin on PRL secretion during different photoperiods of the day in prepubertal and pubertal healthy subjectsR Mauri, P Lissoni, M Resentini, et al.
Pageof 29